Biliary decompression promotes Kupffer cell recovery in obstructive jaundice.

W D Clements, M McCaigue, P Erwin, I Halliday, B J Rowlands
Author Information
  1. W D Clements: Department of Surgery, Queen's University of Belfast.

Abstract

BACKGROUND: Jaundiced patients undergoing surgical procedures have an increased risk of Gram negative sepsis with potential morbidity and mortality. Depressed Kupffer cell clearance capacity (KCCC) predisposes jaundiced patients to endotoxaemia and its sequelae. Biliary decompression remains the main therapeutic strategy in obstructive jaundice.
AIMS: This study investigates the efficacy of internal (ID) and external biliary drainage (ED) on KCCC in an experimental model of extrahepatic biliary obstruction.
METHODS: Adult male Wistar rats (250-300 g) were assigned to one of six groups: sham operated, where the bile duct was mobilised but not divided; bile duct ligation (BDL) for three weeks, and sham operated or BDL for three weeks followed by a second laparotomy and further 21 days of ID or ED, by way of choledochoduodenostomy or choledochovesical fistula respectively. KCCC was measured using an isolated hepatic perfusion technique with FITC labelled latex particles (0.75 mu) as the test probe. Plasma was assayed for bilirubin, endotoxin, and anticore glycolipid antibody (ACGA) concentrations.
RESULTS: Jaundiced rats had reduced KCCC (p < 0.001), increased concentrations of ACGA (p < 0.001), and endotoxin (p < 0.001) compared with controls. Biliary drainage for three weeks produced a recovery in KCCC and normalisation of endotoxin and ACGA concentrations, however, external drainage was less effective than ID (p < 0.01).
CONCLUSIONS: These data support the hypothesis that endotoxaemia and its mediated effects are integral in the pathophysiology of jaundice. Furthermore, a short period of internal biliary drainage is a useful therapeutic strategy in restoring Kupffer cell function and negating systemic endotoxaemia and consequent complications in biliary obstruction.

References

  1. Am J Gastroenterol. 1995 Feb;90(2):233-8 [PMID: 7847292]
  2. Br J Surg. 1990 Apr;77(4):440-2 [PMID: 2160307]
  3. Am J Surg. 1981 Jan;141(1):66-72 [PMID: 6970004]
  4. Br J Surg. 1991 May;78(5):568-71 [PMID: 2059808]
  5. Br J Surg. 1985 Dec;72(12):942-5 [PMID: 3936565]
  6. J Immunol. 1979 Nov;123(5):2133-43 [PMID: 489976]
  7. Acta Chir Scand. 1972;138(2):159-64 [PMID: 5036413]
  8. Biochem J. 1966 Nov;101(2):284-92 [PMID: 5966267]
  9. Gastrointest Endosc. 1995 Jan;41(1):25-32 [PMID: 7698621]
  10. Ann Surg. 1994 Jan;219(1):18-24 [PMID: 7507656]
  11. Br J Surg. 1992 Jul;79(7):648-52 [PMID: 1643476]
  12. J Nutr Biochem. 1990 Dec;1(12):620-8 [PMID: 15539181]
  13. Br J Surg. 1983 Sep;70(9):535-8 [PMID: 6616158]
  14. J Reticuloendothel Soc. 1983 Mar;33(3):207-20 [PMID: 6300396]
  15. Surgery. 1990 Aug;108(2):370-4; discussion 374-5 [PMID: 2200158]
  16. Lab Anim Sci. 1991 Jan;41(1):82-3 [PMID: 1849597]
  17. Am J Surg. 1990 Jan;159(1):79-84 [PMID: 2136788]
  18. Surg Clin North Am. 1988 Feb;68(1):181-97 [PMID: 3277303]
  19. Eur J Surg Oncol. 1994 Oct;20(5):580-4 [PMID: 7523198]
  20. Surg Gynecol Obstet. 1993 Jan;176(1):1-10 [PMID: 7678945]
  21. Virchows Arch B Cell Pathol Incl Mol Pathol. 1988;54(5):303-11 [PMID: 2895543]
  22. Scand J Gastroenterol Suppl. 1992;194:8-12 [PMID: 1298053]
  23. Br J Surg. 1984 Mar;71(3):234-8 [PMID: 6607760]
  24. Hepatology. 1992 Jul;16(1):255-66 [PMID: 1319954]
  25. J Surg Res. 1994 Aug;57(2):316-36 [PMID: 8028341]
  26. J Surg Res. 1986 Aug;41(2):113-25 [PMID: 3762122]
  27. Am J Surg. 1989 Feb;157(2):256-63 [PMID: 2644864]
  28. World J Surg. 1992 May-Jun;16(3):536-40 [PMID: 1589993]
  29. Eur J Surg. 1992 Mar;158(3):165-6 [PMID: 1356456]
  30. Ann Surg. 1993 Apr;217(4):356-68 [PMID: 7682052]
  31. J Pediatr Surg. 1991 Apr;26(4):401-5; discussion 405-6 [PMID: 2056399]
  32. Biochem Soc Trans. 1994 Feb;22(1):24S [PMID: 8206241]
  33. Br J Surg. 1990 Nov;77(11):1229-32 [PMID: 2253000]
  34. HPB Surg. 1991 Jun;4(2):81-94 [PMID: 1931783]
  35. Lab Invest. 1974 Aug;31(2):161-9 [PMID: 4852621]
  36. Arch Surg. 1993 Feb;128(2):200-4; discussion 204-5 [PMID: 8431121]
  37. Surgery. 1992 Nov;112(5):891-6 [PMID: 1440241]
  38. J Med Microbiol. 1977 May;10(2):241-4 [PMID: 323490]
  39. Am J Surg. 1979 Dec;138(6):809-13 [PMID: 507297]
  40. Am J Surg. 1982 Sep;144(3):325-9 [PMID: 7114371]
  41. Lancet. 1974 Oct 12;2(7885):883-6 [PMID: 4137592]
  42. Br J Surg. 1987 Dec;74(12):1091-4 [PMID: 3427351]
  43. J Surg Res. 1977 Nov;23(5):321-31 [PMID: 909295]
  44. Vox Sang. 1987;52(4):272-80 [PMID: 2820153]
  45. Gastroenterology. 1990 Feb;98(2):478-85 [PMID: 2295404]
  46. Br Med J. 1970 Nov 21;4(5733):472-4 [PMID: 4921235]

MeSH Term

Animals
Antibodies
Biliary Tract Surgical Procedures
Cholestasis
Endotoxins
Kupffer Cells
Male
Perfusion
Rats
Rats, Wistar

Chemicals

Antibodies
Endotoxins

Word Cloud

Created with Highcharts 10.0.0KCCC0biliarydrainagep<KupffercellendotoxaemiaBiliaryjaundiceIDthreeweeksendotoxinACGAconcentrations001JaundicedpatientsincreaseddecompressiontherapeuticstrategyobstructiveinternalexternalEDobstructionratsshamoperatedbileductBDLrecoveryBACKGROUND:undergoingsurgicalproceduresriskGramnegativesepsispotentialmorbiditymortalityDepressedclearancecapacitypredisposesjaundicedsequelaeremainsmainAIMS:studyinvestigatesefficacyexperimentalmodelextrahepaticMETHODS:AdultmaleWistar250-300gassignedonesixgroups:mobiliseddividedligationfollowedsecondlaparotomy21dayswaycholedochoduodenostomycholedochovesicalfistularespectivelymeasuredusingisolatedhepaticperfusiontechniqueFITClabelledlatexparticles75mutestprobePlasmaassayedbilirubinanticoreglycolipidantibodyRESULTS:reducedcomparedcontrolsproducednormalisationhoweverlesseffective01CONCLUSIONS:datasupporthypothesismediatedeffectsintegralpathophysiologyFurthermoreshortperiodusefulrestoringfunctionnegatingsystemicconsequentcomplicationspromotes

Similar Articles

Cited By (13)